Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results> HANSON PHARMACEUTICAL (03692.HK) Full-Year Net Profit RMB5.555 Billion, Up 27.1%; Final Dividend HKD0.20
Recommend 2 Positive 3 Negative 2 |
||||
|
||||
|
HANSON PHARMACEUTICAL (03692.HK) announced its results for the fiscal year 2025, reporting revenue of RMB15.028 billion, a year-on-year increase of 22.6%. The company recorded a net profit of RMB5.555 billion, up 27.1%, primarily driven by increased sales revenue from innovative drugs and collaborative products. Earnings per share were RMB0.93. A final dividend of HKD0.20 was declared, bringing the total annual dividend, including the interim dividend, to HKD0.4316. (de/d) Auto-translated by third-party software This translation was auto-generated by third-party software. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
